Professor Brendan Crabb AC PhD FAHMS is an infectious disease researcher with a special interest on malaria. His research group develops and exploits genetic approaches to better understand malaria parasite biology, principally to help prioritise vaccine and drug targets.
Since 2008 he has been the Director and CEO of the Macfarlane Burnet Institute for Medical Research and Public Health Ltd (Burnet Institute). He is the past-President of the Association of Australian Medical Research Institutes (AAMRI), the peak body for independent medical research Institutes in Australia.
He is currently a Fellow of the Australian Academy of Health and Medical Sciences (FAHMS), serves on the Council of the National Health and Medical Research Council (NHMRC) of Australia and on the boards of both AAMRI and Research Australia.
Internationally, he serves on the International Advisory Boards of both the Sanger Institute (UK) and the Vaccine Science Portfolio Advisory Committee at PATH/MVI (USA), a group he chaired for the previous four years. In his home state of Victoria, Professor Crabb serves on the Victorian Government’s Science, Medical Research and Technology (SMaRT) Panel and is President of the Victorian Chapter of AAMRI.
Apart from his own research and leading the Burnet Institute, Australia’s leading independent global health research organisation, Professor Crabb has a strong general interest in promoting policies that embed medical research into local and international health program delivery, especially the translation of research into health solutions.
In 2015, he was awarded a Companion of the Order of Australia, Australia’s highest civilian honour, for contributions to better understanding infectious diseases and their impact on poor and vulnerable communities, and for fostering medical research as an advocate, mentor and administrator.